OTCMKTS:BNXTF BioNxt Solutions (BNXTF) Stock Price, News & Analysis $0.27 0.00 (0.00%) As of 09/25/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and Trends About BioNxt Solutions Stock (OTCMKTS:BNXTF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioNxt Solutions alerts:Sign Up Key Stats Today's Range$0.27▼$0.2750-Day Range$0.21▼$0.2852-Week Range$0.14▼$0.79VolumeN/AAverage Volume444 shsMarket Capitalization$36.22 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioNxt Solutions Inc. is a biotechnology company focused on developing pharmaceutical and drug-delivery technologies. Its work centers on alternative dosage forms designed to improve the administration, absorption, and convenience of medicines, including oral dissolvable and sublingual films, transdermal systems, and other novel delivery platforms. The company’s development activities have included pharmaceutical products and delivery systems targeting areas such as neurological disorders and other medical conditions. BioNxt has also pursued the development and commercialization of proprietary formulations and related technologies through partnerships and operating activities in North America and Europe, including Germany. BioNxt Solutions was formerly known as XPhyto Therapeutics Corp. and adopted its current name as it focused more directly on pharmaceutical development and drug-delivery solutions. The company is headquartered in Vancouver, British Columbia, and its leadership has included Chief Executive Officer Hugh Rogers.AI Generated. May Contain Errors. Read More Receive BNXTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioNxt Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNXTF Stock News HeadlinesBioNxt Solutions (OTCMKTS:BNXTF) Shares Down 6.7% - What's Next?September 20, 2026 | americanbankingnews.comBioNxt Extends Convertible Debentures and Issues 16.9 Million WarrantsAugust 21, 2026 | tipranks.comBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses. | Decentralized Masters (Ad)BioNxt Solutions Inc.: BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier Ahead of Human Clinical StudiesAugust 20, 2026 | finanznachrichten.deBioNxt Solutions Inc.August 12, 2026 | barrons.comBioNxt Solutions Inc.: BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer ExemptionJune 23, 2026 | finanznachrichten.deBioNxt Solutions announces one-year extension on $4.58M debt; issues 16.9M bonus warrantsJune 11, 2026 | msn.comBioNxt Solutions Inc.: BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical DevelopmentMay 20, 2026 | finanznachrichten.deSee More Headlines BNXTF Stock Analysis - Frequently Asked Questions How have BNXTF shares performed this year? BioNxt Solutions' stock was trading at $0.4430 at the beginning of the year. Since then, BNXTF shares have decreased by 39.9% and is now trading at $0.2662. How were BioNxt Solutions' earnings last quarter? BioNxt Solutions Inc. (OTCMKTS:BNXTF) issued its quarterly earnings data on Friday, August, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. How do I buy shares of BioNxt Solutions? Shares of BNXTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/28/2026Today9/29/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:BNXTF CIKN/A Webwww.xphyto.com Phone780-818-6422FaxN/AEmployees20Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$5.03 million Net MarginsN/A Pretax Margin-84,700.00% Return on EquityN/A Return on Assets-860.91% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.19 Sales & Book Value Annual Sales$20 thousand Price / Sales1,811.22 Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-5.32Miscellaneous Outstanding Shares136,090,000Free FloatN/AMarket Cap$36.22 million OptionableNot Optionable Beta0.75 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (OTCMKTS:BNXTF) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNxt Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNxt Solutions With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
